Diabetes Mellitus, Type 1
Showing NaN - NaN of 32
TrialNet Pathway to Prevention of T1D
Recruiting
- Diabetes Mellitus, Type 1
-
Orange, California
- +21 more
Feb 18, 2022
Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)
Completed
- Diabetes Mellitus, Type 1
- AG019 - Low Dose
- +5 more
-
Birmingham, Alabama
- +17 more
Nov 9, 2021
Diabetes, Type 1 Trial in Minneapolis (Experimental hyperglycemia)
Recruiting
- Diabetes Mellitus, Type 1
- Experimental hyperglycemia
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 25, 2021
Diabetes, Type 1 Trial in Minneapolis (Experimental hypoglycemia)
Recruiting
- Diabetes Mellitus, Type 1
- Experimental hypoglycemia
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 7, 2021
Diabetes, Type 1 Trial in Worldwide (Oral Insulin, Placebo)
Completed
- Diabetes Mellitus, Type 1
- Oral Insulin
- Placebo
-
San Francisco, California
- +17 more
Apr 27, 2020
Diabetes, Type 1 Trial in Canada, United States (Mycophenolate mofeteil (MMF), Daclizumab (DZB), Placebo control for
Completed
- Diabetes Mellitus, Type 1
- Mycophenolate mofeteil (MMF)
- +3 more
-
Los Angeles, California
- +10 more
Apr 27, 2020
Diabetes, Type 1 Trial in Canada, United States (Parenteral Insulin, Close Observation, Oral Insulin)
Completed
- Diabetes Mellitus, Type 1
- Parenteral Insulin
- +3 more
-
Los Angeles, California
- +14 more
Apr 22, 2020
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- insulin aspart
-
Encino, California
- +91 more
Nov 12, 2019
Diabetes, Type 1 Trial in United States (Nasal Glucagon, Intramuscular Glucagon)
Completed
- Diabetes Mellitus, Type 1
- Nasal Glucagon
- Intramuscular Glucagon
-
Aurora, Colorado
- +7 more
Sep 5, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Tucson, Arizona
- +151 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Phoenix, Arizona
- +154 more
May 22, 2019
Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- Insulin lispro
- +4 more
-
Escondido, California
- +18 more
Feb 5, 2019
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Diabetes, Type 1 Trial in United States (Nasal Glucagon, Intramuscular Glucagon)
Completed
- Diabetes Mellitus, Type 1
- Nasal Glucagon
- Intramuscular Glucagon
-
Aurora, Colorado
- +6 more
Aug 1, 2018
Diabetes, Type 1 Trial in United States (Placebo, PF-06342674 Dose A, PF-06342674 Dose B)
Completed
- Diabetes Mellitus, Type 1
- Placebo
- +4 more
-
San Diego, California
- +20 more
Oct 27, 2017
Diabetes, Type 1 Trial in Israel, United States (LY2605541, Insulin glargine)
Completed
- Diabetes Mellitus, Type 1
- LY2605541
- Insulin glargine
-
Chula Vista, California
- +12 more
Mar 17, 2018
Diabetes, Type 1 Trial in Worldwide (Glargine, LY2605541, Insulin Lispro)
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in United Kingdom, United States (FlorenceM, Medtronic insulin
Completed
- Diabetes Mellitus
- +4 more
- FlorenceM
- Medtronic insulin pump 640G
-
Aurora, Colorado
- +7 more
Mar 12, 2018
Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)
Terminated
- Diabetes Mellitus, Type 1
-
Birmingham, Alabama
- +16 more
Oct 11, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- +2 more
-
La Mesa, California
- +80 more
Feb 9, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Little Rock, Arkansas
- +181 more
Jan 16, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- liraglutide
- placebo
-
Phoenix, Arizona
- +119 more
Dec 15, 2016
Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin lispro
- insulin aspart
-
Mobile, Alabama
- +51 more
Dec 21, 2016
Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin human
- +2 more
-
Birmingham, Alabama
- +75 more
Dec 21, 2016